Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 2, 2002, Pages 344-352

  Jian, James Jer Min ^a   Cheng, Skye Hongiun ^a,b   Tsai, Stella Yu Chen ^a,b   Yen, Kai Cheng Lawrence ^a   Chu, Nei Min ^a   Chan, Kwan Yee ^a   Tan, Tran Der ^a   Cheng, Jason Chia Hsien ^a,b   Lin, Yen Chun ^a   Leu, Szu Yun ^a   Hsieh, Cheng I ^a   Tsou, Mei Hua ^a   Lin, Ching Yuan ^a   Huang, Andrew T ^a,b  

^a KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Hyperfractionated; Nasopharyngeal carcinoma; Radiotherapy

Indexed keywords

BRAIN; CHEMOTHERAPY; DISEASES; PATIENT TREATMENT; TOXICITY; TUMORS;

RADIATION TREATMENT;

RADIOTHERAPY;

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BRAIN STEM; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG TOLERANCE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION DOSE; SKULL; SURVIVAL RATE; THORACIC SPINE; TIME; TREATMENT INDICATION; TREATMENT OUTCOME; TUBE FEEDING; WEIGHT REDUCTION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; PATIENT COMPLIANCE; STOMATITIS; SURVIVAL RATE; WEIGHT LOSS;

EID: 0036603608     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02709-8     Document Type: Article

References (27)

1. Comparison of AJCC and 1997 classifications for nasopharyngeal carcinoma. American Joint Committee on Cancer
2. Staging of nasopharyngeal carcinoma: From Ho's to the new UICC system
3. T-classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma
4. Computed tomography findings of bony regeneration after radiotherapy for nasopharyngeal carcinoma with skull base destruction: Implications for local control
5. Carcinoma of the nasopharynx: Factors affecting prognosis
6. Concomitant chemotherapy and radiotherapy for locally advanced nasopharyngeal carcinoma
7. Hyperfractionated radiation therapy in brain stem tumors: Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group Study #8495
8. Hyperfractionation versus conventional fractionation in nasopharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy
9. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
10. Spinal cord dose from standard head and neck irradiation: Implications for three-dimensional treatment planning
11. Superiority of chemo-radiotherapy vs radiotherapy in patients with locally advanced nasopharyngeal cancer: Preliminary results of Intergroup (0099) Randomized Study
12. Nonparametric estimation from incomplete observation
13. Chi-square test with one degree of freedom: Extensions of the Mantel-Haenszel procedure
14. Improved local control for early T-stage nasopharyngeal carcinoma - A tale of two hospitals
15. Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy
16. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer. Phase III Randomized Intergroup Study 0099
17. Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy
18. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves locoregional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial
19. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurological complication
20. Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma
21. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The UCSF experience
22. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma
23. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma
24. Skull-base invasion of nasopharyngeal carcinoma: Magnetic resonance imaging findings and therapeutic implications
25. Nasopharyngeal carcinoma: MRI and CT assessment
26. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: Impact on future clinical trials